STRATA Skin Sciences Inc
SSKN
Get informed when a big investor buys or sells
+ FollowMarket Cap$604.53K
Close$
$-2.26
1835.5% downside
Current Fair Value
1835.5% downsideOvervalued by 1835.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $604,527.00 |
|---|---|
| Enterprise Value | $11.90 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.35 |
| Beta | -0.05 |
| Outstanding Shares | 5,888,199 |
Return
| Return on Equity | -215.30% |
|---|---|
| Return on Assets | -20.51% |
| Return on Invested Capital | -107.67% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | 0.12 |
| Price to Sales | 0.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | -2.92 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.61 |
| Debt to Equity | 6.6 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 26, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$5.26 M
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
$5.53 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About STRATA Skin Sciences Inc
CEO: Dolev Rafaeli STRATA Skin Sciences is a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTR...